Over seröz kistadenomu duvarında ektopik adrenal

Ektopik adrenal çocuklarda nispeten sık görülen bir durumdur. En sık lokalizasyon erkek genital sistemi, özellikle de spermatik korddur. Kadın genital sistemi de ektopik adrenal dokusunun sık görüldüğü bir bölgedir, ancak over lokalizasyonu çok nadirdir. Yirmi bir yaşında kadın hasta karında şişlik, pelvik ağrı ve menstrüasyon düzensizliği nedeniyle başvurdu. Ultrasonografide sol ovarian bölgede 25 cm çaplı kistik kitle saptandı. Ameliyatla çıkartılan kist seröz sıvıyla doluydu ve duvarında 0.2 cm çapta sarı renkte nodül görüldü. Mikroskobik bakıda kist iç yüzü seröz kübik epitelle döşeliydi. Kist duvarındaki nodül ise iyi sınırlıydı ve adrenal dokudan oluşuyordu. Patolojik tanı, seröz kistadenom ve ektopik adrenal doku olarak geldi.Ectopic adrenal tissue is a relatively common finding, especially in children. The most common localization is the male genital system, especially the spermatic cord. Female genital tract is also a common site for ectopic adrenal tissue but, ovarian localization is very rare. A 21-year-old woman presented with complaints of abdominal swelling, pelvic pain and menstrual irregularity. Ultrasonographic examination revealed a 25 cm cystic mass in the left ovarian region. The cyst which was removed surgically, was filled with serous fluid and there was a 0.2 cm yellowish nodule within the wall. Serous cubic epithelium was lining the inner portion of the cyst. The nodule within the cyst wall was well defined and consisted of adrenal tissue

The efficacy of cinacalcet in the treatment of hyperparathyroidism in Turkish hemodialysis patient population

WOS: 000393291900012OBJECTIVE: Cinacalcet reduces parathyroid hormone levels by increasing the sensitivity of the parathyroid gland to calcium. in this study, we firstly aimed to evaluate the efficacy of cinacalcet in Turkish hemodialysis patients. MATERIAL and METHODS: 4483 hemodialysis patients were screened and 469 patients who had used cinacalcet were included in the study. the patients were divided into 4 groups according to drug usage durations (Group 1: 3 months, Group 2: 6 months, Group 3: 9 months and Group 4: 12 months). the patients' Parathormone, Ca, P and CaxP levels at the 3rd, 6th, 9th and 12th months were compared to the start of treatment and previous months. RESULTS: the levels of Parathormone, Ca, P and CaxP significantly decreased compared to their initial levels in all groups (from 1412 pg/ml to 1222 pg/mL for Parathormone, p< 0,001) in the 3rd month. However, this reduction was not continued in the subsequent months (Parathormone: 1381 pg/ml for the 12th month). CONCLUSION: Cinacalcet may not provide adequate benefit in control of hyperparathyroidism in Turkish hemodialysis patient population

Improvement of the Thrust-Torque Ratio of An Unmanned Helicopter by Using the ABC Algorithm

-</p